Provided by Tiger Fintech (Singapore) Pte. Ltd.

HBM HOLDINGS-B

8.270
-0.180-2.13%
Volume:6.89M
Turnover:56.55M
Market Cap:6.84B
PE:291.35
High:8.730
Open:8.600
Low:8.030
Close:8.450
Loading ...

Company Profile

Company Name:
HBM HOLDINGS-B
Exchange:
SEHK
Establishment Date:
2016
Employees:
183
Office Location:
Building A3,Suite 202,218 Xinghu Street,Suzhou Industrial Park,Suzhou,Jiangsu Province,China
Website:
- -
Zip Code:
215123
Fax:
- -
Introduction:
Hbm Holdings Ltd is an investment holding company mainly engaged in the business of developing therapeutics in the fields of immuno-oncology and immunology diseases. The Company's products include HBM9161, HBM4003, HBM7008 and HBM1020. Batoclimab (HBM9161) is mainly used for immune thrombocytopenia (ITP), graves’ ophthalmopathy (GO), myasthenia gravis (MG), neuromyelitis optica spectrum disorder (NMOSD). Tanfanercept (HBM9036) is mainly used for dry eye disease (DED). The Company also researches and develops immuno-oncology portfolio, including internally developed next generation immune-oncology assets targeting immune-desert, immune-excluded and inflamed tumors. The Company owns Harbour Mice Platform, generating fully human monoclonal antibodies in the classical two heavy and two light chain H2L2 format as well as heavy chain only (HCAb) format.

Directors

Name
Position
WANG Jin Song
Chairman of the Board,Executive Director,Member of the Remuneration and Assessment Committee,Chairman of the Nomination Committee
RONG Yi Ping
Executive Director
Robert Irwin Kamen
Independent Director,Member of the Nomination Committee
Xiaoping Ye
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Member
Albert R.Collinson
Independent Director,Chairman of the Remuneration and Assessment Committee,Audit Committee Member
CHEN Wei Wei
Independent Director,Member of the Nomination Committee,Audit Committee Chairman

Shareholders

Name
Position
WANG Jin Song
CEO
TAO Xiao Lu
Vice General Manager,Other Senior Executives
LV Ying Yi
Corporate Secretary
LIU Yi
Corporate Secretary
RONG Yi Ping
Chief Science Officer